J.P. Morgan Global High Yield & Leveraged Finance Conference

More documents

Recommendations

Info

2 FINANCIALS & OUTLOOK Q4 & Fiscal Year 2010 © I J.P. Morgan Conference I March 1, 2011 20
Q4 − Profit & Loss US-$ in millions Q4 2009 Q4 2010 Growth in % Net Revenue 3,035 3,167 4 Operating income (EBIT) 491 539 10 EBIT-margin in % 16.2 17.0 Interest expense, net 75 74 Income before taxes 416 465 12 Income tax expense 145 169 Tax rate in % 35 36 Non-controlling interest 24 25 Net income attributable to FMC AG & Co. KGaA 247 271 10 5%cc © I J.P. Morgan Conference I March 1, 2011 21
Page 1 and 2: J.P. Morgan Global High Yield & Lev
Page 3 and 4: 1 BUSINESS UPDATE Q4 & Fiscal Year
Page 5 and 6: Fiscal Year − Revenue split by re
Page 7 and 8: Q4 − Revenue split by region Tota
Page 9 and 10: Fiscal Year− Dialysis Services Ou
Page 11 and 12: Q4│FY − Dialysis Services│Rev
Page 13 and 14: Fiscal Year − Dialysis Products I
Page 15 and 16: GOAL 10 − Long-term target overac
Page 17 and 18: 2010│2011 − Expansion & Product
Page 19: 2010 − Summary Leadership Mainta
Page 23 and 24: 2010 − Day Sales Outstanding (DSO
Page 25 and 26: Fiscal Year − Cash Flow US-$ in m
Page 27 and 28: Financial Cushion As of December 31
Page 29 and 30: 2011− Outlook Another record year
Page 31 and 32: World Leader in Dialysis Services 1
Page 33 and 34: Market Opportunity by Region In bil
Page 35 and 36: Major Production Sites Dialysis cli
Page 37 and 38: Continued Growth Opportunities 2008
Page 39 and 40: Operating Margin Development North
Page 41 and 42: Attachment 1 Reconciliation of non-
Page 43 and 44: Attachment 3 Reconciliation of non-
Page 45 and 46: Safe Harbor Statement: This present

J.P. Morgan Global High Yield & Leveraged Finance Conference

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?